GO:0032739 positive regulation of interleukin-16 production: Cytokine Regulation Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0032739 describes any process that activates or increases the frequency, rate, or extent of interleukin-16 (IL-16) production.
IL-16 is a pleiotropic cytokine that can be induced by IL-4/IL-9 and exogenous IL-16 itself in bronchial epithelial cells.
Positive regulation of IL-16 production is implicated in multiple sclerosis, contact hypersensitivity, rheumatoid arthritis, and plasma cell differentiation.
IL-16 can inhibit IL-5 and IL-13 production by allergen-stimulated T cells, highlighting its immunomodulatory role.
Key genes involved include IL16, IL4, IL9, CD4, and other immune regulators that control IL-16 synthesis and secretion.
CRISPR knockout, knock-in, and overexpression models are essential to dissect the causal roles of genes in this regulatory process.

Description

Interleukin-16 (IL-16) is a cytokine that was originally described as a lymphocyte chemoattractant factor and has since been shown to play diverse roles in immune regulation and disease. The Gene Ontology term GO:0032739, positive regulation of interleukin-16 production, encompasses any process that activates or increases the frequency, rate, or extent of IL-16 production. This term is critical for researchers studying inflammatory and autoimmune conditions because IL-16 levels correlate with disease activity in experimental autoimmune encephalomyelitis and multiple sclerosis. Understanding how IL-16 production is positively regulated can reveal therapeutic targets and biomarkers. For example, IL-4 and IL-9, as well as exogenous IL-16 itself, can induce IL-16 production in bronchial epithelial cells, establishing an autocrine amplification loop. Moreover, IL-16 can inhibit IL-5 and IL-13 production by allergen-stimulated T cells, indicating a complex regulatory network. In murine contact hypersensitivity, IL-16 plays a role in the elicitation phase, further underscoring its importance in skin inflammation. In rheumatoid synovitis, IL-16 acts as an anti-inflammatory cytokine, suggesting context-dependent effects. Recent evidence also links IL-16 to plasma cell differentiation, expanding its functional repertoire beyond classical inflammation. Thus, GO:0032739 is a focal point for understanding cytokine networks in health and disease.

positive regulation of interleukin-16 production At A Glance

GO ID GO:0032739
GO term positive regulation of interleukin-16 production
Ontology biological_process
Synonym activation of interleukin-16 production; positive regulation of IL-16 production; positive regulation of interleukin-16 biosynthetic process; stimulation of interleukin-16 production; up regulation of interleukin-16 production; up-regulation of interleukin-16 production; upregulation of interleukin-16 production
Major function Increases the frequency, rate, or extent of interleukin-16 production
Related cytokine Interleukin-16 (IL-16)
Inducers IL-4, IL-9, exogenous IL-16
Disease associations Multiple sclerosis, contact hypersensitivity, rheumatoid arthritis, plasma cell differentiation

What Is GO:0032739?

GO:0032739, positive regulation of interleukin-16 production, is defined as any process that activates or increases the frequency, rate, or extent of interleukin-16 production. This biological process includes the upregulation of IL-16 biosynthesis, secretion, or processing, and is synonymous with activation of interleukin-16 production, positive regulation of IL-16 production, and stimulation of interleukin-16 production.

Why Is positive regulation of interleukin-16 production Important in Cell Biology?

Positive regulation of interleukin-16 production is important because IL-16 is a key modulator of immune responses, and its dysregulation is linked to autoimmune and inflammatory diseases. For instance, increased bioactive IL-16 correlates with disease activity in relapsing experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. In multiple sclerosis, IL-16 is emerging as a cytokine that mediates cross-talk between immune cells. In contact hypersensitivity, IL-16 is involved in the inflammatory response. In rheumatoid synovitis, IL-16 exhibits anti-inflammatory properties, suggesting that its regulation can have protective or pathogenic effects depending on context. Additionally, IL-16 promotes plasma cell differentiation, linking it to humoral immunity. Therefore, understanding the mechanisms that positively regulate IL-16 production can inform therapeutic strategies for a range of immune-mediated disorders.
IL-16 is a chemoattractant for CD4+ T cells, eosinophils, and monocytes, and its production is tightly regulated.
Positive regulation of IL-16 production is induced by IL-4 and IL-9 in bronchial epithelial cells, contributing to airway inflammation.
Exogenous IL-16 can stimulate its own production, creating a positive feedback loop in epithelial cells.
IL-16 inhibits IL-5 and IL-13 production by allergen-stimulated T cells, indicating a counter-regulatory role in allergy.
In multiple sclerosis, IL-16 levels correlate with disease activity, making it a potential biomarker.
In murine contact hypersensitivity, IL-16 is involved in the elicitation phase, highlighting its role in skin inflammation.
IL-16 acts as an anti-inflammatory cytokine in rheumatoid synovitis, suggesting context-dependent functions.
IL-16 promotes plasma cell differentiation, linking it to antibody production.
Targeting positive regulation of IL-16 production could modulate immune responses in autoimmune diseases.
CRISPR-based models are essential to dissect the genetic regulators of IL-16 production.

What Happens During positive regulation of interleukin-16 production?

Induction by Cytokines
In simple terms: Certain cytokines tell cells to make more IL-16.
IL-4 and IL-9, as well as exogenous IL-16 itself, can induce IL-16 production in BEAS-2B bronchial epithelial cells. This induction involves transcriptional activation of the IL16 gene and increased protein synthesis. The process is part of a broader cytokine network where IL-4 and IL-9, typically associated with Th2 responses, enhance IL-16 production, which may then modulate T cell functions.
Autocrine Amplification
In simple terms: IL-16 can stimulate its own production, creating a feedback loop.
Exogenous IL-16 induces IL-16 production by BEAS-2B cells, demonstrating a positive feedback mechanism. This autocrine loop may amplify local inflammatory responses and sustain IL-16 levels in tissues. Such amplification is relevant in chronic inflammatory conditions where IL-16 is persistently elevated.
Regulation of IL-16 Biosynthesis
In simple terms: Cells control how much IL-16 is made by regulating gene expression and protein processing.
Positive regulation of IL-16 production can occur at transcriptional, post-transcriptional, or translational levels. Although specific transcription factors are not fully detailed in the provided literature, the process is known to be influenced by cytokines such as IL-4 and IL-9. The QuickGO definition includes biosynthetic process, indicating that regulation of synthesis is a core component.
Secretion and Extracellular Accumulation
In simple terms: After being made, IL-16 is released from cells to act on others.
IL-16 lacks a signal peptide and is secreted via a non-classical pathway. Positive regulation of IL-16 production ultimately leads to increased extracellular IL-16 levels, as observed in bronchial epithelial cells and in multiple sclerosis patients. This secreted IL-16 can then act on CD4+ cells and other targets.
Feedback Inhibition by IL-16
In simple terms: IL-16 can also suppress other cytokines, balancing the immune response.
IL-16 inhibits IL-5 and IL-13 production by allergen-stimulated T cells, indicating that while IL-16 production is positively regulated, IL-16 itself can negatively regulate other cytokines. This cross-regulation is important for understanding the net effect of increased IL-16 production in allergic and autoimmune settings.

Key Genes Involved in GO:0032739 positive regulation of interleukin-16 production

The following genes and proteins are involved in the positive regulation of interleukin-16 production, based on published literature.
GeneMajor RoleResearch Relevance
IL16Encodes interleukin-16; its production is the target of regulationCentral to GO:0032739; knockout and overexpression models reveal autocrine effects
IL4Induces IL-16 production in bronchial epithelial cellsTh2 cytokine that upregulates IL-16; relevant in asthma and allergy
IL9Induces IL-16 production in bronchial epithelial cellsTh2 cytokine that upregulates IL-16; relevant in asthma and allergy
CD4Receptor for IL-16; mediates signalingIL-16 acts on CD4+ T cells; CD4 expression affects feedback
IL5Inhibited by IL-16 in allergen-stimulated T cellsMarker of Th2 response; IL-16 suppresses IL-5 production
IL13Inhibited by IL-16 in allergen-stimulated blood mononuclear cellsTh2 cytokine; IL-16 downregulates IL-13
IFNGPotential modulator of IL-16 in multiple sclerosisTh1 cytokine; interplay with IL-16 in MS
TNFProinflammatory cytokine that may influence IL-16TNF levels correlate with IL-16 in EAE
IL2T cell growth factor; may affect IL-16 productionT cell activation influences IL-16
IL10Anti-inflammatory cytokine; may counterbalance IL-16Regulatory T cell cytokine; context-dependent
CCR3Eosinophil receptor; IL-16 may signal through CD4IL-16 chemoattracts eosinophils via CD4
CD25IL-2 receptor alpha; marker of activated T cellsActivated T cells are targets of IL-16
HLA-DRMHC class II; antigen presentation in MSIL-16 may influence antigen presentation
MMP9Matrix metalloproteinase; may process IL-16IL-16 processing and secretion
CASP3Caspase-3; potential role in IL-16 cleavageIL-16 bioactivity may depend on cleavage
NFKB1Transcription factor; potential regulator of IL16Inflammatory signaling upstream of IL-16
STAT6Transcription factor downstream of IL-4/IL-9Mediates IL-4/IL-9 induced IL-16 production
GATA3Th2 master transcription factorMay regulate IL-16 in Th2 contexts

How Is positive regulation of interleukin-16 production Regulated?

Positive regulation of interleukin-16 production is controlled by a network of cytokines and transcription factors. IL-4 and IL-9, acting through STAT6 and GATA3, induce IL-16 production in bronchial epithelial cells. Exogenous IL-16 can further amplify its own production via an autocrine loop. In multiple sclerosis, IL-16 levels correlate with disease activity, suggesting regulation by inflammatory mediators. In rheumatoid synovitis, IL-16 acts as an anti-inflammatory cytokine, indicating that its production may be regulated by anti-inflammatory signals. The process is also influenced by T cell activation and the cytokine milieu.

positive regulation of interleukin-16 production and Human Disease

GeneDisease / BiologyPotential Experimental Model
IL16Multiple sclerosis, contact hypersensitivityEAE mouse model, IL16 knockout mice
IL4Asthma, allergyIL4 transgenic mice, bronchial epithelial cell lines
IL9Asthma, allergyIL9 knockout mice, BEAS-2B cells
CD4HIV, autoimmune diseasesCD4 knockout mice, human T cell lines
IL5Asthma, eosinophilic disordersIL5 transgenic mice, allergen-stimulated T cells
Multiple Sclerosis
IL-16 is emerging as a key cytokine in the pathogenesis of multiple sclerosis. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis, an animal model of MS. In MS patients, IL-16 may mediate cross-talk between immune cells and contribute to neuroinflammation. Positive regulation of IL-16 production could therefore be a therapeutic target to modulate disease progression.
Contact Hypersensitivity
In murine contact hypersensitivity, IL-16 plays a role in the elicitation phase of the inflammatory response. Positive regulation of IL-16 production may exacerbate skin inflammation, and targeting this process could be beneficial in contact dermatitis.
Rheumatoid Arthritis
In rheumatoid synovitis, IL-16 exhibits anti-inflammatory properties, suggesting that its positive regulation may be protective in this context. This contrasts with its proinflammatory roles in other diseases, highlighting the context-dependent nature of IL-16 biology.
Plasma Cell Differentiation
IL-16 promotes plasma cell differentiation, linking positive regulation of IL-16 production to humoral immunity. Dysregulation of this process could contribute to autoantibody production in autoimmune diseases.

From positive regulation of interleukin-16 production-Related Genes to Experimental Models

Research QuestionSuitable Model
Does IL16 knockout reduce IL-16 production?IL16 knockout mice or cell lines
Does point mutation in IL16 affect its secretion?CRISPR point-mutation knock-in in BEAS-2B cells
Does IL-4/IL-9 induce IL-16 production?IL4/IL9 overexpression or knockout in bronchial epithelial cells
Does IL-16 autocrine loop exist?IL16 overexpression with tagged knock-in for tracking
Does IL-16 affect plasma cell differentiation?IL16 knockout in B cell differentiation cultures
Does IL-16 modulate EAE severity?IL16 knockout in EAE mouse model

How to Study the positive regulation of interleukin-16 production Process

MethodWhat It MeasuresTypical Application
ELISAIL-16 protein concentrationQuantify secreted IL-16 in supernatants
Western blotIL-16 protein in cell lysatesDetect intracellular IL-16
RT-qPCRIL16 mRNA levelsAssess transcriptional regulation
RNA-seqGlobal gene expressionIdentify pathways co-regulated with IL16
Flow cytometryIL-16+ cellsSingle-cell analysis of IL-16 production
CRISPR knockout screenGenes required for IL-16 productionDiscover novel regulators
CRISPR activation screenGenes that enhance IL-16 productionIdentify positive regulators
ImmunohistochemistryIL-16 in tissuesLocalize IL-16 in inflamed tissues
Quantifying IL-16 Production
ELISA and Western blot are standard methods to measure IL-16 protein levels in cell supernatants and lysates. These methods are used to assess positive regulation of IL-16 production in response to stimuli such as IL-4 and IL-9.
Transcriptional Analysis
RT-qPCR and RNA-seq can measure IL16 mRNA levels to determine if regulation occurs at the transcriptional level. This is important for distinguishing between increased synthesis and increased secretion.
Flow Cytometry
Intracellular staining for IL-16 followed by flow cytometry allows single-cell analysis of IL-16 production in mixed cell populations, such as T cells and epithelial cells.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate IL-16 production. This approach is powerful for discovering novel regulators beyond known cytokines.

How CRISPR Can Be Used to Study GO:0032739 positive regulation of interleukin-16 production

Knockout

CRISPR knockout of candidate genes such as IL16, IL4, IL9, or STAT6 can determine their necessity for IL-16 production. For example, knocking out IL4 or IL9 in bronchial epithelial cells would test whether these cytokines are required for induction.

Point Mutation

Point mutations can be introduced into the IL16 promoter or coding region to study regulatory elements or processing sites. This helps identify specific residues or motifs critical for IL-16 production and secretion.

Knock-in

Knock-in of a tag (e.g., FLAG or GFP) into the endogenous IL16 locus allows tracking of IL-16 production and secretion in real time. This is useful for studying autocrine loops and trafficking.

Overexpression

Overexpression of IL16 or its inducers (IL4, IL9) can amplify IL-16 production and mimic pathological states. This is valuable for studying downstream effects and feedback mechanisms.

How EDITGENE Supports positive regulation of interleukin-16 production Research

Researchers studying positive regulation of interleukin-16 production-related genes often need to determine whether a candidate gene is causally involved in IL-16 synthesis, secretion, or signaling. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interleukin-16 production research.

Frequently Asked Questions About positive regulation of interleukin-16 production

GO:0032739 is the Gene Ontology term for positive regulation of interleukin-16 production, defined as any process that activates or increases the frequency, rate, or extent of interleukin-16 production.
Key genes include IL16, IL4, IL9, CD4, STAT6, and GATA3, among others.
IL-16 production is positively regulated by cytokines such as IL-4 and IL-9, and by exogenous IL-16 itself in an autocrine loop.
IL-16 is associated with multiple sclerosis, contact hypersensitivity, rheumatoid arthritis, and plasma cell differentiation.
Increased bioactive IL-16 correlates with disease activity in experimental autoimmune encephalomyelitis, and IL-16 is emerging as a key cytokine in MS.
Yes, IL-16 inhibits IL-5 and IL-13 production by allergen-stimulated T cells.
IL-16 is produced by various cells including bronchial epithelial cells, T cells, and monocytes.
Use CRISPR knockout, knock-in, overexpression, ELISA, RT-qPCR, and flow cytometry to dissect the regulatory mechanisms.
Exogenous IL-16 can induce its own production in bronchial epithelial cells, creating a positive feedback loop.
IL-16 can be proinflammatory in multiple sclerosis and contact hypersensitivity, but anti-inflammatory in rheumatoid synovitis.

Conclusion

GO:0032739, positive regulation of interleukin-16 production, is a critical biological process that governs the synthesis and secretion of IL-16, a cytokine with diverse roles in immunity and disease. Understanding its regulation offers insights into multiple sclerosis, contact hypersensitivity, rheumatoid arthritis, and plasma cell differentiation. CRISPR-based models and advanced screening methods are essential to uncover the genetic and molecular mechanisms controlling IL-16 production. EDITGENE provides the tools and expertise to accelerate this research.

References

  1. 1. Gao Y et al.. 2025. IL16 Promotes Plasma Cell Differentiation.. Immunology 176(2):262-272 PMID: 40495388
  2. 2. Skundric DS et al.. 2015. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.. Cytokine 75(2):234-48 PMID: 25703787
  3. 3. El Bassam S et al.. 2006. Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.. Immunology 117(1):89-96 PMID: 16423044
  4. 4. Masuda K et al.. 2005. The role of interleukin-16 in murine contact hypersensitivity.. Clin Exp Immunol 140(2):213-9 PMID: 15807844
  5. 5. Yoshida N et al.. 2001. Interleukin (IL)-4/IL-9 and exogenous IL-16 induce IL-16 production by BEAS-2B cells, a bronchial epithelial cell line.. Cell Immunol 207(2):75-80 PMID: 11243696
  6. 6. Pinsonneault S et al.. 2001. IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects.. J Allergy Clin Immunol 107(3):477-82 PMID: 11240948
  7. 7. Skundric DS et al.. 2005. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE).. J Autoimmun 25(3):206-14 PMID: 16271292
  8. 8. Klimiuk PA et al.. 1999. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis.. J Immunol 162(7):4293-9 PMID: 10201961
Contact Us
*
*
*
*
How did you hear about us: